Genetics of Neonatal Encephalopathy and Related Disorders
1 other identifier
observational
300
1 country
1
Brief Summary
Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to neonatal encephalopathy (NE) and related disorders. These findings may help explain the broad spectrum of clinical features and outcomes seen in individuals with a history of NE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2026
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 3, 2025
CompletedFirst Posted
Study publicly available on registry
September 10, 2025
CompletedStudy Start
First participant enrolled
February 4, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2035
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2035
March 11, 2026
March 1, 2026
9.6 years
September 3, 2025
March 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Diagnostic yield
The diagnostic yield of genomic sequencing will be calculated as the percentage of enrolled participants with NE who receive a genetic diagnosis.
10 years
Study Arms (1)
Neonatal Encephalopathy
Individuals with a history of NE who are less than 6 years old at the time of enrollment and available biological parents. Must be followed clinically at Boston Children's Hospital. Research genomic sequencing with CLIA confirmation of diagnostic findings. Those with an existing genetic diagnosis or who are deceased prior to enrollment are ineligible.
Eligibility Criteria
Patients at Boston Children's Hospital and available biological parents
You may qualify if:
- Diagnosed with neonatal encephalopathy during the neonatal period as documented in the electronic medical record
- Less than 6 years old at the time of study enrollment
- Patient at Boston Children's Hospital
You may not qualify if:
- Genetic cause of NE already identified
- Deceased prior to enrollment
- Parent criteria:
- \- Biological parent of eligible proband (see above)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
Biospecimen
DNA, blood, saliva, buccal, tissue samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Pediatrics
Study Record Dates
First Submitted
September 3, 2025
First Posted
September 10, 2025
Study Start
February 4, 2026
Primary Completion (Estimated)
September 1, 2035
Study Completion (Estimated)
September 1, 2035
Last Updated
March 11, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
De-identified clinical and genomic data may be shared with approved researchers at Boston Children's Hospital and with approved external collaborators.